Global Alopecia Market is Expected to Grow at a CAGR of 8.6% in the Forecast Period of 2020-2025.

The global alopecia market is being driven by the rising prevalence of the disease due to surging consumption of tobacco, cigarettes and alcohol, unhealthy food habits, and rising stress indices among the working-class population, which are seen as potential causes for the disease. Moreover, the expanding geriatric population, along with a high demand for surgical hair transplants, is expected to further the market growth. In addition, it is anticipated that increased incidences of chronic diseases such as rheumatoid arthritis, polycystic ovary syndrome (PCOS), acute stress disorder, hyperthyroidism, hypothyroidism, cancer, lupus, and hypopituitarism will fuel market growth as they to contribute to the occurrence of alopecia.

North America is one of the leading markets for alopecia owing to the development in technology, increasing prevalence of the disease among the population, and rising disposable incomes. The Asia Pacific region is expected to demonstrate the fastest growth in the coming years. The key factors driving the regional market growth are the large population base and rising consumer awareness of available treatment options. Improvement in the economy and increased per capita healthcare expenses are projected to introduce strong commercial opportunities in developing countries such as India, China, and Singapore for the market.

The global alopecia market is being driven by the rising R&D activities taking place in the industry and the growing approvals of new drugs by governmental organisations. In March 2020, Eli Lilly and Incyte (NASDAQ: INCY) announced that the FDA had granted baricitinib the designation of breakthrough therapy for treating patients with alopecia areata.

Market Analysis by Disease Type, Drug Type, Route of Administration, Gender, Distribution Channel, and Region:

• The market on the basis of disease type can be divided into androgenic alopecia, alopecia areata, ciatricial alopecia, traction alopecia, and alopecia totalis. 
• Based on drug type, the industry can be divided into Minoxidil and Finasteride, among others.
• Based on the route of administration, the industry can be divided into oral, topical, and injectable.
• Based on gender, the industry can be divided into males and females.
• The distribution channels in the alopecia market include hospitals, retail pharmacies, and online pharmacies.
• The regional markets for alopecia include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• The global alopecia market is being driven by the increasing global prevalence of alopecia and the rise in global healthcare expenditure.
• The technological advancements in alopecia treatment is furthering the market growth.
• The growing consumer awareness about the disease and treatments and the rising emphasis on outer appearance is catalysing the growth of the market.

Key Offerings of the Report:

• The EMR report gives an overview of the global alopecia market for the periods (2015-2019) and (2020-2025).
• The report also offers the historical (2015-2019) and forecast (2020-2025) markets for disease types, drug types, routes of administration, genders, distribution channels, and major regions of the global alopecia market.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.

The major players in the global alopecia market are Johnson and Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lexington Intl., LLC, Merck & Co. Inc., Cirrus Hair Centers, Transitions Hair, Capillus, and Follica Inc., among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us:

EMR is a leading business intelligence company, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Contact Us:

Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790